Announcements Trials
Browse Landscape

Phase

Phase 1 74Phase 1/2 37Phase EARLY_PHASE1 7Phase 2 4Phase NA 1

Status

Not yet recruiting 3Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 590Neoplasms 499Prostatic Neoplasms 316Lung Neoplasms 239Colorectal Neoplasms 201Motor Activity 134Carcinoma, Non-Small-Cell Lung 116Uterine Cervical Neoplasms 114Pancreatic Neoplasms 109Brain Neoplasms 109Head and Neck Neoplasms 104Stomach Neoplasms 100Rectal Neoplasms 98Carcinoma, Hepatocellular 97Ovarian Neoplasms 86Colonic Neoplasms 86Neoplasm Metastasis 68Esophageal Neoplasms 67Multiple Myeloma 65Hematologic Neoplasms 62Urinary Bladder Neoplasms 60Melanoma 59Sarcoma 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 58Glioblastoma 58Endometrial Neoplasms 57Glioma 53Anxiety Disorders 51Lymphoma 50Gastrointestinal Neoplasms 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Recruiting × Advanced Solid Tumors × Clear all
NCT07185243 2025-09-22

A Study to Evaluate Combination Therapy of Oncolytic Vaccinia Virus (hV01) and PD-1 Inhibitor in Advanced Solid Tumors.

Hangzhou Converd Co., Ltd.

Phase NA Recruiting
24 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡